Urol. praxi, 2014; 15(5): 221-226

Possible causes of incontinence and their solutions

MUDr.Miroslava Romžová
Urologická klinika, FN Hradec Králové

Urinary incontinence is a condition that can occur in both sexes, regardless of age. Their formation is involved in many other well defined

disease. A thorough diagnosis is essential for the correct identification of the type of incontinence and successful therapy.

Keywords: incontinence, enuresis, pelvic floor exercises, anticholinergics, Sling surgery, artificial sphincter

Published: December 16, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Romžová M. Possible causes of incontinence and their solutions. Urol. praxi. 2014;15(5):221-226.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Haylen BT, Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Rizk DE, Sand PK, Schaer GN. An international urogynecological association (IUGA)/international kontinence society (ICS) join report on the terminology for fiale pelvic floor dysfuntion. Int Urogynecol J, 2010; 21: 5-26. Go to original source... Go to PubMed...
    2. Struppl D. Současné trendy v chirurgické léčbě stresové inkontinence moči. Urol. prax, 2009; 10(5): 274-278.
    3. Broďák M, Holub L, Košina J, Romžová M, Pacovský J, Navrátil P, Louda. Prevalence symptomů dolních močových cest a hyperaktivního močového měchýře u žen a mužů v běžné populaci. Urol. prax, 2008; 1: 19-21.
    4. Abrams P, Cordozo L, Fall M, Griffin D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function. Report from the standardisation subcommittee of the Internation continence society. Neurourol Urodyn, 2002; 21: 167-178. Go to original source... Go to PubMed...
    5. Blaivas JG, Appel LA, Fantl JA, Leach G, McGuire E, Resnick N, et al. Defoinition and classification of urinary inkontinence: recomenddation of the Urodynamics soiety. Neurourol Urogyn, 1997; 16: 149-151. Go to original source...
    6. Ženíšek J. Inkontinence moče po radikální prostatektomii. Urol. praxi. 2010; 11(1): 26-28.
    7. Burešová E, Vidlář A, Študent V. Postprostatektomická inkontinence moči a možnosti léčby. Urol. praxi, 1013; 14(4): 166-169.
    8. Peyromaure M, Ravery V, Boccon-Gibod L. The management of stress urinary incontinence after radical prostatectomy. BJU 2002; 90: 155-161. Go to original source... Go to PubMed...
    9. Kyoko S, Blaivas JG. Adult onset nocturnal enuresis. J Urol 2001; 165: 1914-1917. Go to original source... Go to PubMed...
    10. Lin AD, Lin AT, Chen KK, Chang LS. Nocturnal enuresis in older adults. J Chin Med Assoc 2004; 67: 136-140. Go to PubMed...
    11. Williams A, Keye A, Naerger H. Adult nocturnal enuresis: guide to causes and treatment. Prescribing in Practice 2005; 23-26.
    12. Miller W. Nocturnal polyuria in older people: pathophysiology and clinical implications. J Am Geriatr Soc 2000; 48: 1321-1329. Go to original source... Go to PubMed...
    13. Romžová M, Hurtová M, Holub l, Pacovský J. Inkontinence moči z pohledu urologa. Med. praxi 2011; 8(5): 222-225.
    14. Kelleher C, Staskin D, Cherian P, et al. Committee 5B. Patient reported outcome assessment. In: Abrams P, Cardozo L, Khoury S, et al. 5th International Consultation on Incontinence, Paris February 2012.
    15. Homma Y, Ando T, Yoshida M, et al. Voiding and incontinence frequencies: variability of diary data and required diary length. Neurourol Urodyn 2002; 21(3): 204-209. Go to original source... Go to PubMed...
    16. Ku JH, Jeong IG, Lim DJ, et al. Voiding diary for the evaluation of urinary incontinence and lower urinary tract symptoms: prospective assessment of patient compliance and burden. Neurourol Urodyn 2004; 23(4): 331-335. Go to original source... Go to PubMed...
    17. Grabe M, Bjerklund-Johansen TE, Botto H, et al. EAU Guidelines on Urological Infections.
    18. Milleman M, Langenstroer P, Guralnick ML. Post-void residual urine volume in women with overactive bladder symptoms. J Urol 2004 Nov; 172(5 Pt 1): 1911-1914. Go to original source... Go to PubMed...
    19. Tseng LH, Liang CC, Chang YL, et al. Postvoid residual urine in women with stress incontinence. Neurourol Urodyn 2008; 27(1): 48-51. Go to original source... Go to PubMed...
    20. Groutz A, Blaivas JG, Chaikin DC, et al. Noninvasive outcome measures of urinary incontinence and lower urinary tract symptoms: a multicenter study of micturition diary and pad tests. J Urol 2000 Sep; 164(3 Pt 1): 698-701. Go to original source... Go to PubMed...
    21. Kegel AH. Progressive resistance exercise in the functional restoration of the perineal muscles. Am J Ostet Gyn, 1948; 56: 238. Go to original source... Go to PubMed...
    22. Bo K. Pelvic floor muscles exercise for the treatment of stress incontinence: an exercise physiology perspective. Int Urogynecol J, 1995; 6: 282. Go to original source...
    23. Cardozo L, Lange R, Voss S, et al. Short- and long-term efficacy and safety of duloxetine in women with predominant stress urinary incontinence. Curr Med Res Opin 2010 Feb; 26(2): 253-261. Go to original source... Go to PubMed...
    24. Filocamo MT, Li Marzi V, Del Popolo G, et al. Pharmacologic treatment in postprostatectomy stress urinary incontinence. Eur Urol 2007 Jun; 51(6): 1559-1564. Go to original source... Go to PubMed...
    25. Cody JD, Jacobs ML, Richardson K, et al. Oestrogen therapy for urinary incontinence in postmenopausal women. Cochrane Database Syst Rev. 2012 Oct 17; 10:CD001405. Go to original source... Go to PubMed...
    26. Marshall VF, Marchetti AA, Krantz KE. The correction of stress incontinence by simple vesicourethral suspension. Surg Gynecol Obstet 1949; 88: 509-512.
    27. Burch JC. Urethrovesical fixation to Cooper's ligament for correction of stress incontinence, cystocele and prolapse. Am J Obstet Gynecol 1961; 81: 281-290. Go to original source... Go to PubMed...
    28. Ward KL, Hilton P, UK and Ireland TVT Trial Group. Tension-free vaginal tape versus colposuspension for primary urodynamic stress incontinence: 5-year follow up. BJOG 2008; 115: 226-233. Go to original source... Go to PubMed...
    29. Martan A, Švabik K, Mašata J, et al. Řešení stresové inkontinence moči u žen operačni metodou TVT-S-vztah mezi léčebným efektem operační metody a změnami hodnot ultrazvukových parametrů. Čes. Gynek. 2008; 73(5): 271-277.
    30. Kirchin V, Page T, Keegan PE, et al. Urethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev 2012 Feb; (2): CD003881. Go to original source...
    31. Fantl JA, Wyman JF, McClish DK, Harkins SW, Elswick RK, Taylor JR. Efficacy of bladder training in older woman with urinary incontinence. JAMA 1995; 265: 609. Go to original source...
    32. Chapple C, Khullar V, Gabriel Z, Dooley JA. The effects of antimuskarinic treatments in overactive bladder: a systematic review and meta-analysis. Eur Urol 2005; 48: 5-26. Go to original source... Go to PubMed...
    33. Poršová M, Kolombo I, Porš J, Kobzanová R, Pabišta R. Urgentní mikce a inkontinence a možnosti jejich farmakologické léčby. Urol. praxi, 2008; 9(6): 302-306.
    34. Verner P. Porovnání účinnosti a vedlejších účinků anticholinergik při léčbě OAB. Urol. praxi, 2010; 11(5): 241-246.
    35. Andersson KE. Antimuscarinic mechanism and the overactive detrusor: an update. Eur. Urol., 2011; 59: 377-386. Go to original source... Go to PubMed...
    36. Nitti VW1, Khullar V, van Kerrebroeck P, Herschorn S, Cambronero J, Angulo JC, Blauwet MB, Dorrepaal C, Siddiqui E, Martin NE. Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies. Int J Clin Pract. 2013 Jul; 67(7): 619-632. doi: 10.1111/ijcp.12194. Epub 2013 May 21. Go to PubMed...
    37. Saks EK, Lily AA. Pharmacologic management of overactive bladder. The female patient, 2010; 11(35): 24-29.
    38. Drlík P. Nykturie - současné možnosti terapie. Urol. praxi, 2010; 11(4): 176-179.
    39. Romžová M. Farmakoterapie urgentní inkontinence a hyperaktivního močového měchýře. Urol. praxi, 2013; 14(2): 9-62.
    40. Kuo HC, Liao CH, Chung SD. Adverse events of intravesical Botulinum Toxin a injections for idiopathic detrusor overactivity: risk factors and influence on treatment outcome. Eur. Urol., 2010; 58: 919-926. Go to original source... Go to PubMed...
    41. Schantz EJ, Johnson EA. Properties and use of botulinum toxin and other microbial neurotoxins in medicine. Microbiological Reviews, 1992; 56(1): 80-99. Go to original source... Go to PubMed...
    42. Apostolidis A, Dasgupta P, Fowler CJ. Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity. Eur Urol, 2006; 49: 644-650. Go to original source... Go to PubMed...
    43. Chancellor MB, de Groat WC. Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the overactive bladder. J Urol, 1999; 162: 3-11. Go to original source... Go to PubMed...
    44. Kim JH, Rival DA, Shenot PJ, Green B, Kennelly M, Ericsson JR, et al. Chancellor MB Intravesical resiniferatoxin for refractory detrusor hyperreflixia: a multicenter, blinded, radomizid, placebo-cotrolled trial. J spinal Cord Med, 2003; 26: 359-363. Go to original source... Go to PubMed...
    45. de Seze M, Gallien P, Denys P, Labat JJ, Serment G, Grise P, et al. Intravesical glucidic capsaicin versus glucidic solvent in neurogenic detrusor overactivity: a double blind controlled randomized study. Neurourol Urodyn, 2006; 25: 752-757. Go to original source... Go to PubMed...
    46. Romžová M, Hurtová M, Pacovský J, Broďák M. Inkontinence moči u neurogenního močového měchýře Urol. praxi, 2010; 11(5): 247-252.
    47. Stárka L, Sosvorová L, Mikšátková P. Herbální přípravky používané při léčbě příznaků benigní hyperplazie prostaty. Urol. praxi, 2012; 13(6): 239-244.
    48. Hušek P, Pacovský J, Košina J, Broďák M. Léčba BHP v České republice v kontextu doporučených postupů EAU. Urol. praxi, 2012; 13(2): 56-61.
    49. Yoshida M, Homma Y, Kawabe K. Silodosin, a novel selective alpha 1A-adrenoreceptor selective antagonist for the treatment of benign prostatic hyperplasia. Expert Opin Investig Drugs. 2007; 16: 1955-1965. Go to original source... Go to PubMed...
    50. Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, N'Dow J, Nordling J, de la Rosette JJ. Guidelines on the Management of Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO). European Association of Urology 2013. Go to original source...
    51. Klečka J, Hora M, Běhounek P, Eret V, Stránský P. Současné možnosti léčby mikčních symptomů dolních cest močových. Urol. praxi, 2010; 11(3): 124-130.
    52. Dvořáček J. Kombinovaná léčba benigní hyperplazie prostaty. Urol. praxi, 2012; 13(4): 148-153.
    53. Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, N´Dow J, Nordling J, de la Rosettte JJ. Guidelines of the Treatment of Non-neurogenic Male LUTS. European Association of Urology 2011. Go to PubMed...
    54. Madersbacher S, Marberger M. Is transurethral resection of the prostate still justified? Br J Urol 1999 Feb; 83(3): 227-237. http://www.ncbi.nlm.nih.gov/pubmed/10233485. Go to original source... Go to PubMed...
    55. Ahyai SA, Gilling P, Kaplan SA, et al. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 2010 Sep; 58(3): 384-397. Go to original source... Go to PubMed...
    56. Ženíšek J. Novinky v léčbě stresové inkontinence u mužů. Urol. praxi, 2014; 15(2): 68-71.
    57. Centemero A, et al. Preoperative pelvic floor muscle exercize for early kontinence after radical prostatectomy: a randomised controlled study. Eur Urol 2010; 57: 1039-1044. Go to original source... Go to PubMed...
    58. Filocamo MT, et al. Pharmacologic treatment in postprostatetctomy stress urinary inkontinence. Eur Urol 2007; 51(6): 1559-1564. Go to original source... Go to PubMed...
    59. Imamoglu MA, et al. The comparison of artificial urinary sphincter implantation and endourethral macroplastique injection for the treatment of postprostatectomy incontinence. Eur Urol 2005; 47(2): 209-213. Go to original source... Go to PubMed...
    60. Scott FB, et al. Treatment of urinary inkontinence by implantace prosthetic sphincter. Urology 1973; 1(3): 252-259. Go to original source... Go to PubMed...
    61. Klijn AJ, Hop WCJ, Mickisch G, Schröder FH, Bosch LHR. The artificial urinary sphincter in men incontinent after radial prostatectomy: 5-years actuarial adequate function rates. BJU 1998; 82: 530-533. Go to original source... Go to PubMed...
    62. Zachoval R, Záleský M, Borovička V, Vik V. Léčba mužské stresové inkontinence pomocí ATOMS. Kongres české urologické společnosti, 2011, Praha.
    63. Reynard JM, Cannon A, Yang Q, Abrams P. A novel therapy for nocturnal polyuria: a double-blind randomized of furosemid against placebo study. Br J Urol 1998; 81: 215-218. Go to original source... Go to PubMed...
    64. Burešová E, Vidlář A, Študent V. Noční inkontinence moči u dospělých. Urol. praxi, 2011; 12(1): 42-43.

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.